Horizon Therapeutics plc (HZNP)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q2 2023 | |||||
| ≡ | Daniel Loeb - Third Point | Buy | 500,000 | 0.75 | |
| ≡ | David Abrams - Abrams Capital Management | Buy | 890,993 | 2.64 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,871 | 0.00 | |
| ≡ | Viking Global Investors | Add 212.07% | 2,489,132 | 0.50 | |
| Q1 2020 | |||||
| ≡ | Viking Global Investors | Buy | 1,991,270 | 0.31 | |
| Q2 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 12.58% | 23,840 | 0.01 | |
| Q3 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 299,590 | 0.07 | |
| Q3 2015 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Add 386.77% | 12,396,016 | 1.10 | |
| Q2 2015 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Buy | 3,204,972 | 0.49 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.